Cargando…
Interactions of Rosiglitazone and Anti-Arrhythmic Drugs in Animal Model
BACKGROUND: Diabetes increases the risk of vascular problems by two times compared with a healthy individual, with deposition of fats in blood vessel and this includes cardiovascular disease. The treatment regimens for patients suffering from both diseases generally include prolonged use of anti-dia...
Autores principales: | Mohammed, YM, Mohammed, EI, Mohiuddin, N, Syeda, SS |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573510/ https://www.ncbi.nlm.nih.gov/pubmed/23440669 http://dx.doi.org/10.4103/2141-9248.105663 |
Ejemplares similares
-
New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models
por: Sharma, Ashish Kumar, et al.
Publicado: (2023) -
Clinical and economic outcomes associated with use of anti-arrhythmic drugs versus ablation in atrial fibrillation
por: Ken-Opurum, Jennifer, et al.
Publicado: (2023) -
Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine
por: Han, Chorong, et al.
Publicado: (2021) -
PLA-PEG Nanoparticles Improve the Anti-Inflammatory Effect of Rosiglitazone on Macrophages by Enhancing Drug Uptake Compared to Free Rosiglitazone
por: Giacalone, Giovanna, et al.
Publicado: (2018) -
Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy
por: Passini, Elisa, et al.
Publicado: (2016)